Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance
Saved in:
Main Authors: | Johnathan Oh (Author), Minal Barve (Author), Neil Senzer (Author), Phylicia Aaron (Author), Luisa Manning (Author), Gladice Wallraven (Author), Ernest Bognar (Author), Laura Stanbery (Author), Staci Horvath (Author), Meghan Manley (Author), John Nemunaitis (Author), Adam Walter (Author), Rodney P. Rocconi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Corrigendum to "Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance" [Gynecol. Oncol. Rep. 34 (2020) 100648]
by: Jonathan Oh, et al.
Published: (2021) -
Rationale for the Use of Homologous Recombination Proficient Molecular Profile as a Biomarker for Therapeutic Targeting in Ovarian Cancer
by: John Nemunaitis, et al.
Published: (2023) -
The Vigil of Brunhild: A Narrative Poem
by: Manning, Frederic, 1882-1935 -
A vigilance alert for forensic odontology: Preservation and maintenance of dental records in Central India
by: Urvashi Tomar, et al.
Published: (2020) -
by: Yuqiao Shen, et al.
Published: (2008)